Listed Price₹111.20
Listing Gain-20.00%
Price Band₹132 - ₹139
Lot Size1,000 shares
Min Bid₹1,39,000
Subscription2.31x
Listed Market Snapshot
₹111.20Listed price from market data
-20.00%listing gain
Issue Amount
₹52.43 Cr
Listed Price
₹111.20
Current Price
₹119.2
Registrar
Skyline Financial Services Private Limited
Timeline•Bookbuilding IPO
Open21 May 2026
Close25 May 2026
Allotment26 May 2026
Listing29 May 2026
Quota Reservation Portions
QIBPortion: 36,000 shares
0.95%HNIPortion: 17,55,000 shares
46.53%RetailPortion: 17,92,000 shares
47.51%Market MakerPortion: 1,89,000 shares
5.01%Minimum Application Bracket Matrix
Retail2 lots / 2,000 shares
₹2,78,000sHNI3 lots / 3,000 shares
₹4,17,000bHNI8 lots / 8,000 shares
₹11,12,000About the Company
Bio Medica Laboratories is a pharmaceutical company engaged in manufacturing parenteral formulations for both human and veterinary healthcare segments. The company produces a wide range of ethical drugs, generic medicines, and OTC products, primarily in liquid and dry powder injectable forms. Its portfolio includes 58 liquid injectables and 15 dry powder injectable products available in single-dose and multi-dose formats. Operating on a B2B contract manufacturing model, the company develops customized formulations according to client requirements. Supported by GMP and GLP certifications, Bio Medica runs two manufacturing facilities in Indore, Madhya Pradesh, focusing on quality production and pharmaceutical formulation development.
Company Promoters
Mr. Mukesh MehtaMr. Pradeep Mehta
Lead Managers
Registrar
Skyline Financial Services Private Limited